All Insights and Resources

Allogeneic

FDA Grants Third RMAT Designation to AlloVir’s T Cell Therapy – Targeting Viruses in Allogeneic Hematopoietic Cell Transplant Patients

21 April 2022

FDA Grants Third RMAT Designation to AlloVir’s T Cell Therapy – Targeting Viruses in Allogeneic Hematopoietic Cell Transplant Patients

AlloVir, has announced the FDA

Scaling Clinical Cell and Gene Therapies

30 March 2022

Scaling Clinical Cell and Gene Therapies

In this webinar, discover how

Defining Flexibility: The Automated Future of Cell Processing

7 February 2022

Defining Flexibility: The Automated Future of Cell Processing

Event Report

Developing Compliant Systems to Modernise the Cell Therapy Manufacturing Workflow

19 January 2022

Developing Compliant Systems to Modernise the Cell Therapy Manufacturing Workflow

Interview - Q&A

POPULAR NEWS ITEMS

<img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" alt="Image" />

26 May 2022

Castle Creek Bioscience Achieves $112.8 Million Financing to Advance Gene Therapies

<img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" alt="Image" />

25 May 2022

Key Takeaways from ASGCT 2022

<img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" alt="Image" />

24 May 2022

Umoja and Lupagen Collaboration Drives Improved Delivery for Next Generation in vivo CAR-T

$FDA RMAT Designation Granted to Fate Therapeutics for FT516 Treatment of Relapsed/Refractory DLBCL$

16 December 2021

FDA RMAT Designation Granted to Fate Therapeutics for FT516 Treatment of Relapsed/Refractory DLBCL

News

Creating Multiplex Allogeneic Cell Therapies: Moving Beyond Editing with Sven Kili

8 December 2021

Creating Multiplex Allogeneic Cell Therapies: Moving Beyond Editing with Sven Kili

Interview - Q&A

EMA to Review First Ever Off-The-Shelf Allogeneic T-Cell Therapy from Atara Bio

1 December 2021

EMA to Review First Ever Off-The-Shelf Allogeneic T-Cell Therapy from Atara Bio

News

Takeda Set to Acquire GammaDelta Therapeutics, Accelerating Allogeneic Cell Therapy Development for Solid Tumours

28 October 2021

Takeda Set to Acquire GammaDelta Therapeutics, Accelerating Allogeneic Cell Therapy Development for Solid Tumours

News

RECOMENDED TOPICS

Tissue Engineering

Viral/Non-Viral Vectors

POPULAR NEWS ITEMS

<img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" alt="Image" />

Castle Creek Bioscience Achieves $112.8 Million Financing to Advance Gene Therapies

<img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" alt="Image" />

Key Takeaways from ASGCT 2022

<img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" alt="Image" />

Umoja and Lupagen Collaboration Drives Improved Delivery for Next Generation in vivo CAR-T

logo_mobile_footer

Company

Resources

Network

Clarion Events Limited is registered in England and Wales, Company Number 00454826, VAT No. GB 843845601 Registered Office: Bedford House, 69-79 Fulham High Street, London, SW6 3JW, United Kingdom.

Phacilitate is a part of Clarion Events Limited. © Phacilitate 2022